相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。(-)-Englerin A is a Potent and Selective Activator of TRPC4 and TRPC5 Calcium Channels
Yasemin Akbulut et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases
Hemant Kumar et al.
NATURAL PRODUCT REPORTS (2014)
Englerin A Stimulates PKCθ to Inhibit Insulin Signaling and to Simultaneously Activate HSF1: Pharmacologically Induced Synthetic Lethality
Carole Sourbier et al.
CANCER CELL (2013)
AMPK activity is regulated by calcium-mediated protein phosphatase 2A activity
S. Park et al.
CELL CALCIUM (2013)
Natural sesquiterpene lactones as inhibitors of Myb-dependent gene expression: Structure-activity relationships
Caroline Schomburg et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis
Stefanie W. Leacock et al.
DISEASE MODELS & MECHANISMS (2012)
Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing's sarcoma
Aleksandar Boro et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group
Richard B. Womer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Protein kinase C, an elusive therapeutic target?
Daria Mochly-Rosen et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Drug-mediated inhibition of Fli-1 for the treatment of leukemia
Y-J Li et al.
BLOOD CANCER JOURNAL (2012)
Carminomycin I Is an Apoptosis Inducer That Targets the Golgi Complex in Clear Cell Renal Carcinoma Cells
Girma M. Woldemichael et al.
CANCER RESEARCH (2011)
Expression of insulin-like growth factor system components in Ewing's sarcoma and their association with survival
Katia Scotlandi et al.
EUROPEAN JOURNAL OF CANCER (2011)
Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model
Iori Takigami et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Identification of ML204, a Novel Potent Antagonist That Selectively Modulates Native TRPC4/C5 Ion Channels
Melissa Miller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Identification of an Inhibitor of the EWS-FLI1 Oncogenic Transcription Factor by High-Throughput Screening
Patrick J. Grohar et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
The transcription factor FOXM1 is a cellular target of the natural product thiostrepton
Nagaratna S. Hegde et al.
NATURE CHEMISTRY (2011)
Activation of PKC isoform βI at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain
Robert R. Rigor et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
High ALDH Activity Identifies Chemotherapy-Resistant Ewing's Sarcoma Stem Cells That Retain Sensitivity to EWS-FLI1 Inhibition
Ola Awad et al.
PLOS ONE (2010)
Downstream EWS/FLI1-upstream Ewing's sarcoma
Heinrich Kovar
GENOME MEDICINE (2010)
EWS/FLI and Its Downstream Target NR0B1 Interact Directly to Modulate Transcription and Oncogenesis in Ewing's Sarcoma
Michelle Kinsey et al.
CANCER RESEARCH (2009)
Identification of Cancer Stem Cells in Ewing's Sarcoma
Mario-Luca Suva et al.
CANCER RESEARCH (2009)
Inhibition of Transcription Factors by Plant-Derived Compounds and their Implications in Inflammation and Cancer
J. L. Rios et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Englerin A, a Selective Inhibitor of Renal Cancer Cell Growth, from Phyllanthus engleri
Ranjala Ratnayake et al.
ORGANIC LETTERS (2009)
The Oncogenic EWS-FLI1 Protein Binds In Vivo GGAA Microsatellite Sequences with Potential Transcriptional Activation Function (Publication with Expression of Concern. See vol. 17, 2022)
Noelle Guillon et al.
PLOS ONE (2009)
GLI1 Is a Central Mediator of EWS/FLI1 Signaling in Ewing Tumors
Jay Joo et al.
PLOS ONE (2009)
Marine natural products as targeted modulators of the transcription factor NF-κB
Florence Folmer et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Childhood and Adolescent Cancer Survival in the US by Race and Ethnicity for the Diagnostic Period 1975-1999
Amy M. Linabery et al.
CANCER (2008)
Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades - Surveillance Epidemiology and End Results data
Natia Esiashvili et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2008)
EWS/FLI Mediates Transcriptional Repression via NKX2.2 during Oncogenic Transformation in Ewing's Sarcoma
Leah A. Owen et al.
PLOS ONE (2008)
IGF1 Is a Common Target Gene of Ewing's Sarcoma Fusion Proteins in Mesenchymal Progenitor Cells
Luisa Cironi et al.
PLOS ONE (2008)
Treatment of metastatuc Ewing Sarcoma/Primitive neuroectodermal tumor of bone: Evaluation of increasing the dose intensity of chemotherapy - A report from the children's oncology group
James S. Miser et al.
PEDIATRIC BLOOD & CANCER (2007)
Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells
Oscar M. Tirado et al.
CANCER RESEARCH (2006)
The NCI60 human tumour cell line anticancer drug screen
Robert H. Shoemaker
NATURE REVIEWS CANCER (2006)
Involvement of calcium in the differential induction of heat shock protein 70 by heat shock protein 90 inhibitors, geldanamycin and radicicol, in human non-small cell lung cancer H460 cells
YS Chang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Oncogene-targeted antisense oligonucleotides for the treatment of Ewing sarcoma
A Maksimenko et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2005)
Identification of p21WAF1/CIP1 as a direct target of EWS-Fli1 oncogenic fusion protein
F Nakatani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Phosphorylation of the EWS IQ domain regulates transcriptional activity of the EWS/ATF1 and EWS/FLI1 fusion proteins
RJ Olsen et al.
ONCOGENE (2001)
分享论文
